MDT

87.67

-1.52%↓

VEEV

234.11

-1.12%↓

A

116.65

-1.95%↓

HQY

86.99

-1.99%↓

PDCO

31.23

-0.03%↓

MDT

87.67

-1.52%↓

VEEV

234.11

-1.12%↓

A

116.65

-1.95%↓

HQY

86.99

-1.99%↓

PDCO

31.23

-0.03%↓

MDT

87.67

-1.52%↓

VEEV

234.11

-1.12%↓

A

116.65

-1.95%↓

HQY

86.99

-1.99%↓

PDCO

31.23

-0.03%↓

MDT

87.67

-1.52%↓

VEEV

234.11

-1.12%↓

A

116.65

-1.95%↓

HQY

86.99

-1.99%↓

PDCO

31.23

-0.03%↓

MDT

87.67

-1.52%↓

VEEV

234.11

-1.12%↓

A

116.65

-1.95%↓

HQY

86.99

-1.99%↓

PDCO

31.23

-0.03%↓

Search

Laboratory Corp of America Holdings

Uždarymo kaina

SektoriusSveikatos priežiūra

229.88 -0.73

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

228.91

Max

230.09

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-26M

144M

Pardavimai

47M

3.3B

P/E

Sektoriaus vid.

26.747

73.239

Pelnas, tenkantis vienai akcijai

3.45

Dividendų pajamingumas

1.22

Pelno marža

4.313

Darbuotojai

60,900

EBITDA

-4.7M

418M

Rekonedacijos

By TipRanks

Rekonedacijos

Stiprus pirkimas

12 mėnesių prognozė

+21.02% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.22%

3.06%

Kitas uždarbis

2025-04-24

Kitas dividendų mokėjimo data

2025-06-11

Kita Ex Dividend data

2025-05-23

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

20B

Ankstesnė atidarymo kaina

230.61

Ankstesnė uždarymo kaina

229.88

Naujienos nuotaikos

By Acuity

47%

53%

141 / 386 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

Laboratory Corp of America Holdings Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-03-30 23:43; UTC

Rinkos pokalbiai

Gold Edges Higher, Supported by Looming U.S. Tariffs -- Market Talk

2025-03-30 23:41; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-03-30 23:41; UTC

Rinkos pokalbiai

Nikkei May Fall Amid Concerns About U.S. Tariffs, Borrowing Costs -- Market Talk

2025-03-30 23:12; UTC

Uždarbis

Tsingtao Brewery 2024 Net CNY4.34B Vs. Net CNY4.27B >0168.HK

2025-03-30 23:12; UTC

Uždarbis

Tsingtao Brewery Board Proposes Final Dividend of CNY2.20/Share >0168.HK

2025-03-30 23:12; UTC

Uždarbis

Tsingtao Brewery 2024 Rev CNY32.14B Vs. CNY33.94B >0168.HK

2025-03-30 22:30; UTC

Uždarbis

Great Wall Motor 2024 Net CNY12.69 Vs. Net CNY7.02B >2333.HK

2025-03-30 22:30; UTC

Uždarbis

Great Wall Motor: Higher Overseas Vehicle Sales Among Factors Supporting Results >2333.HK

2025-03-30 22:30; UTC

Uždarbis

Great Wall Motor 2024 Rev CNY202.20B Vs. CNY173.21B >2333.HK

2025-03-30 21:44; UTC

Rinkos pokalbiai

Barclays Favors Core Bonds Over Equities as Tariffs Loom -- Market Talk

2025-03-30 21:24; UTC

Rinkos pokalbiai

Early Polling Shows Labor's Support Firms Before Australia Vote -- Market Talk

2025-03-30 21:23; UTC

Svarbiausios naujienos

Trump Team Weighs Broader, Higher Tariffs -- WSJ

2025-03-30 16:23; UTC

Svarbiausios naujienos

Tesla's EV Credit Income Is Still Rolling In -- for Now -- Barrons.com

2025-03-30 09:30; UTC

Svarbiausios naujienos

The AI Data-Center Boom Is Coming to America's Heartland -- WSJ

2025-03-30 09:30; UTC

Svarbiausios naujienos

Tariffs on Screws Are Already Hitting Manufacturers -- WSJ

2025-03-29 13:00; UTC

Svarbiausios naujienos

Trump's Trade War Arrives in America's Heartland -- WSJ

2025-03-29 11:00; UTC

Svarbiausios naujienos

Selling Your House This Spring? You Might Need to Cut the Price -- Heard on the Street -- WSJ

2025-03-29 09:30; UTC

Svarbiausios naujienos

The Auto Union Boss Who Went From Trump Foe to Tariff Cheerleader -- WSJ

2025-03-29 08:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-03-29 08:20; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2025-03-29 00:00; UTC

Svarbiausios naujienos

The Drone-Delivery Service Beating Amazon to Your Front Door -- WSJ

2025-03-28 23:16; UTC

Įsigijimai, susijungimai, perėmimai

CoreWeave Debuts: A Big IPO in a Slow Year -- Barrons.com

2025-03-28 22:21; UTC

Svarbiausios naujienos

Inflation, Consumer Fears Fuel Stock Selloff -- WSJ

2025-03-28 21:49; UTC

Svarbiausios naujienos

FCC Investigates Disney for DEI Practices, Chair Says -- 2nd Update

2025-03-28 21:28; UTC

Svarbiausios naujienos

Stocks Fall on Tariff, Consumer Sentiment Fears -- WSJ

2025-03-28 20:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2025-03-28 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-03-28 20:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2025-03-28 20:40; UTC

Svarbiausios naujienos

OpenAI's Latest Funding Round Comes With a $20 Billion Catch -- WSJ

2025-03-28 20:36; UTC

Svarbiausios naujienos

Consumers' Mood Sours in March With Gloomier Economic Outlook -- 4th Update

Akcijų palyginimas

Kainos pokytis

Laboratory Corp of America Holdings Prognozė

Kainos tikslas

By TipRanks

21.02% į viršų

12 mėnesių prognozė

Vidutinis 278.38 USD  21.02%

Aukščiausias 300 USD

Žemiausias 248 USD

Remiantis 14 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Laboratory Corp of America Holdings kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

14 ratings

11

Pirkti

3

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

196.14 / 197.94Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bullish Evidence

Vidutinės trukmės periodas

Strong Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

141 / 386 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Laboratory Corp of America Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.